Goldcal-Kit Tablet (1+3 belongs to a group of medications called 'antiosteoporotic medications used to prevent and treat age-related elderly osteoporosis and postmenopausal osteoporosis in women (after menopause). Goldcal-Kit Tablet (1+3 helps to reduce the risk of spine and hip fractures. Osteoporosis is a medical condition in which bone becomes thin or weak. When a woman reaches her menopause stages, her ovaries stop making the female hormone (estrogen) responsible for maintaining a woman's bone health. Due to the loss of estrogen, bone loss starts, and bones become weak. The earlier a woman reaches menopause, the more the chances of osteoporosis. If proper treatment is not provided, it can even result in brittle bones, increasing bone fracture risk. 

Goldcal-Kit Tablet (1+3 consists of three medicines: Ibandronic acid (bisphosphonates), Calcium (mineral) and Cholecalciferol (Vitamin D3). Ibandronic acid is a bisphosphonate that prevents bone fracture by slowing bone loss, keeping the bones strong and increasing bone thickness. It also helps rebuild bones, reducing the risk of spine and hip fractures. Calcium is a mineral used to prevent or treat a calcium deficiency. It provides essential nutrients to maintain bone formation and maintenance. Cholecalciferol is a steroid hormone produced in the skin when exposed to ultraviolet light or obtained from food sources. It helps maintain blood calcium and phosphorus levels and mineralization of bone.

Your doctor will advise you how often you need to take Goldcal-Kit Tablet (1+3 based on your medical condition. Goldcal-Kit Tablet (1+3 may cause undesirable effects like stomach pain, heartburn, difficulty swallowing, or pain upon swallowing. Most of these side effects of Goldcal-Kit Tablet (1+3 do not require medical attention and gradually resolve over time. However, if the side effects persist or worsen, stop taking Goldcal-Kit Tablet (1+3 and consult your doctor. 

If you are known to be allergic to Goldcal-Kit Tablet (1+3 or its inactive components, please inform your doctor. Pregnant or breastfeeding women should consult their doctor before taking Goldcal-Kit Tablet (1+3. Higher doses of Vitamin D than the recommended daily dose should be used in pregnant women only when advised by the doctor. Goldcal-Kit Tablet (1+3 passes into the breast milk; hence breastfeeding mothers need medical advice before starting Goldcal-Kit Tablet (1+3. Goldcal-Kit Tablet (1+3 should not be given to children or adolescents whose age is less than 18 years.

Goldcal-Kit Tablet (1+3 consists of three medicines, namely, Ibandronic acid (bisphosphonates), Calcium (mineral), and Cholecalciferol (Vitamin D3). Ibandronic acid is a bisphosphonate that helps maintain strong bones and reduces fracture chances. It also increases bone thickness and rebuilds bones, reducing the risk of spine and hip fractures. It is also indicated for the treatment of increasing bone mass in men with osteoporosis, glucocorticoid-induced osteoporosis and Paget's disease of bone. Calcium is a mineral used to prevent or treat a calcium deficiency. It provides essential nutrients to maintain bone formation and maintenance. Cholecalciferol is a steroid hormone produced in the skin when exposed to ultraviolet light or obtained from food sources. It is a provitamin that is converted into a vitamin after intake. Cholecalciferol is a form of Vitamin D and helps maintain blood calcium and phosphorus levels and bone mineralisation. It treats and prevents bone disorders, such as rickets and osteomalacia. Together, Goldcal-Kit Tablet (1+3 is used to treat low blood calcium levels. It effectively treats conditions caused by low calcium levels in the body like Vitamin D deficiency, osteoporosis in postmenopausal women and the elderly (above 65 years of age), hypoparathyroidism, latent tetany, and rickets or osteomalacia.

Do not take Goldcal-Kit Tablet (1+3 if you are allergic to Goldcal-Kit Tablet (1+3 or its inactive components. Pregnant ladies should first consult with their doctor before taking Goldcal-Kit Tablet (1+3 as it is not known whether this medicine will harm an unborn baby. Breastfeeding women should first consult with the doctor before taking Goldcal-Kit Tablet (1+3 as it passes into breast milk and may affect the infant. Goldcal-Kit Tablet (1+3 is not recommended if you have hypercalcaemia (high calcium levels), hypervitaminosis D (high vitamin D levels), have problems in the oesophagus (food pipe) and malabsorption syndrome (difficulty absorbing nutrition from food).  After taking this medicine, a person should sit upright or stand for at least half an hour, Ibandronic acid in Goldcal-Kit Tablet (1+3 can cause serious stomach or oesophagus problems. Goldcal-Kit Tablet (1+3 can increase the risk of jaw bone problems (osteonecrosis), especially in those treated with steroids, chemotherapy, radiation, cancer, blood cell disorders, and pre-existing dental problems. Brief your medical history if you have any heart/kidney/liver/blood vessel diseases, kidney stones, sarcoidosis (growth of inflammatory cells in different parts of the body), Crohn's disease (inflammatory bowel disease), Whipple's disease (bacterial infection affecting joints and digestive system), achlorhydria (little or no stomach acid), low levels of bile, and phosphate imbalance. Goldcal-Kit Tablet (1+3 is only an only part of a complete program that includes diet modification, regular exercise, bone mineral density testing, and consuming calcium and vitamin supplements. Drinking alcohol can affect calcium absorption, therefore, it is advised to limit the alcohol intake while using Goldcal-Kit Tablet (1+3.

• Certain diagnostic test like bone density scan should be done regularly to check bone mineral density (BMD) while using Goldcal-Kit Tablet (1+3. 
• Intake of Goldcal-Kit Tablet (1+3 can cause false test result of bone imaging, so if you are taking Goldcal-Kit Tablet (1+3, let your doctor know before any bone test. 
• Goldcal-Kit Tablet (1+3 may interfere with cholesterol tests, hence please inform your doctor and laboratory staff that you are taking Goldcal-Kit Tablet (1+3 before undergoing blood tests.
• Clinical monitoring of serum electrolyte concentrations and cardiac function is recommended.